quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:00:00·30d
PRRelease
Healthpeak Properties Inc. logo
Zealand Pharma A/S logo

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

DOC· Healthpeak Properties Inc.ZEAL· Zealand Pharma A/S
Real EstateHealth Care
Original source

Companies

  • DOC
    Healthpeak Properties Inc.
    Real Estate
  • ZEAL
    Zealand Pharma A/S
    Health Care

Recent analyst ratings

  • Apr 20DOCUpdateUBS$17.00
  • Feb 5DOCUpdateArgus-
  • Jan 9DOCUpdateGoldman$17.00
  • Dec 16DOCUpdateJefferies$17.00
  • Oct 1DOCUpdateCantor Fitzgerald$20.00
  • Sep 15DOCUpdateRaymond James$20.00

Related

  • ANALYST3d
    UBS initiated coverage on Healthpeak Properties with a new price target
  • PR4d
    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
  • PR4d
    Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2026
  • PR9d
    Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
  • PR15d
    Healthpeak Properties Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and Webcast
  • PR17d
    Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026
  • PR23d
    Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Healthpeak Properties Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022